Home Blog Page 6623

Cities urged to build upwards but ditch skyscraper obsession

The north view of the Manhattan skyline is seen from the 86th floor observation deck of the Empire State Building in midtown Manhattan, New York City, June 24, 2020. — REUTERS/MIKE SEGAR

TALLER BUILDINGS are key to enhancing quality of life as the world’s urban population grows, but cities should not become obsessed with skyscrapers and must prepare for horizontal expansion as newcomers arrive, the World Bank said on Wednesday.

Urban build-up worldwide grew by 30% between 1990 and 2015, with new buildings covering an area roughly the size of Sri Lanka, the bank said in a report that was based on satellite data analysis for almost 10,000 cities.

In poor countries about 90% of new buildings sprung up at the edges of cities, extending their boundaries horizontally, while in rich nations about 35% were built on empty sites within urban centers, the study found.

Such findings appear at odds with the main focus of urban planning in recent years, which has been to create compact cities by building upwards.

But the report’s co-author, Somik Lall, said that while taller buildings and high-density cities do bring benefits, such a model should be adapted to local conditions. “The obsession should not be about building skyscrapers but the passion should be about building liveable cities,” Mr. Lall, the World Bank’s lead urban economist, told the Thomson Reuters Foundation by phone.

Whether urban hubs grow vertically, horizontally or within existing spaces is tied to economic demand, the report said.

With about 70% of the world’s population expected to live in urban areas by 2050, up from 55% at present, cities should plan to accommodate all three types of development or risk facing uncontrolled sprawl, overcrowding and congestion, Mr. Lall said.

Low-income cities tend to look like “pancakes,” growing wide and flat, as newcomers crowd into low-built quarters or settle on the outskirts where land is cheaper, according to the report.

As incomes grow, so do buildings, with richer cities taking the shape of “pyramids,” the research found.

Pyramid-shaped cities are generally more liveable — allowing inhabitants to enjoy more floor space in a dense environment — and more productive, as the reduced distance between workplaces and employees boosts productivity, the report said.

They are also better for the environment as sprawling peripheries encroach on surrounding natural areas and often lack adequate transport links, fueling traffic and pollution.

“If managed well, cities that take a more pyramid-like shape can provide an impetus to accelerate sustainable development by getting people out of cars, cutting commute times and limiting greenhouse gas emissions,” Mr. Lall said.

Yet, cities cannot leapfrog from “pancake” to “pyramid” with planning regulations alone, as new built central high-rises risk remaining vacant if people cannot afford to live in them, the World Bank researchers said.

For developing cities in particular, it is vital to prepare for horizontal expansion, building transport links and basic infrastructures to ensure liveable conditions on the outskirts and lay the groundwork for future development, the report said. —

“The COVID-19 pandemic has highlighted the life-and-death implications of crowded neighborhoods that are ill-equipped to curb the spread of disease,” Juergen Voegele, the bank’s vice president for sustainable development, said in a foreword. 

“As countries slowly extricate themselves from the pandemic, planning for a better urban future requires understanding the forces that have shaped the cities we inhabit today.” — Thomson Reuters Foundation

US to detail global distribution plan for 80M vaccine doses

REUTERS

SAN JOSE, Costa Rica — The United States will announce in the next two weeks how it plans to distribute 80 million coronavirus disease 2019 (COVID-19) vaccine doses it has pledged globally, US Secretary of State Antony Blinken said on Tuesday.

Speaking at a joint news conference with Costa Rican President Carlos Alvarado, Mr. Blinken said the administration of US President Joseph R. Biden would focus on equitable distribution of the vaccines and not tie political strings to the process, a criticism at times directed at China.

“Sometime in the next week to two weeks — we will be announcing the process by which we will distribute those vaccines, what the criteria are, how we will do it,” Mr. Blinken said during his first trip as secretary of state to Latin America, which is fighting to contain COVID-19.

“We will distribute vaccines without political requirements of those receiving them.”

On Monday, Biden said his administration would send at least 20 million doses of the Pfizer, Inc./BioNTech SE , Moderna, Inc. and Johnson & Johnson vaccines, on top of 60 million AstraZeneca Plc doses he had already planned to give to other countries.

The Biden administration has been under pressure to share vaccines to help curb worsening outbreaks from India to Brazil, where health experts fear new, more contagious coronavirus variants could undermine the effectiveness of available shots.

Mr. Blinken said the announcement would reveal the criteria and details of the process but that the United States would focus on the equitable distribution and work in coordination of the COVAX vaccine sharing facility.

As the pandemic outlook within the United States brightens with advancing vaccinations, the aid pledge is central to the administration’s drive to use US vaccine supply as a tool to counter Chinese and Russian vaccine diplomacy.

A senior State Department official, when asked if the United States during this trip made vaccine commitments, to Central America or Costa Rica specifically, said no region or country specific pledges had been made.

“We don’t know what the final distribution is going to be. A lot of it has to do with essentially epidemiology and where the science says that we should be dedicating those vaccines to prevent further spread,” the official told reporters in a briefing. 

Mr. Biden, who has loaned some unused vaccines to Canada and Mexico and donated funds to a multilateral vaccination effort for poor countries, in April said the White House was still looking at its options for eventually sending vaccines to Canada, Central America and elsewhere.

Costa Rica’s President Alvarado stressed that his country was hoping for prompt news on vaccine distribution. — Reuters

Conservation center in Mindoro aims to protect island’s biodiversity

Image courtesy of the Mindoro Biodiversity Foundation, Inc. (MBCFI)

A biodiversity conservation center being constructed in Puerto Galera aims to promote Mindoro’s unique flora and fauna and educate people on climate change.  

A project of the Mindoro Biodiversity Foundation, Inc. (MBCFI), which undertakes the protection and preservation of Mindoro Island, the Mindoro Biodiversity Conservation Center in Barangay Dulangan, Puerto Galera, is composed of a Mangyan heritage hall, where the Mangyans can showcase their cultural heritage and sell their handicrafts; a greenhouse, where visitors can try their hand at bio-intensive gardening and nursery landscaping; and a research laboratory, where scientists and researchers can process specimens from key biodiversity areas in the island.  

“We have constructed 40% of buildings 1 and 2,” said Grace C. Diamante, executive director of MBCFI, at a May 27 virtual event. The first phase of construction is expected to finish before the year ends, she added, although there have been delays due to bad weather.  

Sponsorship opportunities  including those that fund the non-profit organization’s programs on scientific research, community-related activities, and information campaigns  are available, Ms. Diamante added. Individuals or groups that donate P515 million will have spaces named after them. 

Located in the southwestern coast of Luzon and northeast of Palawan, Mindoro Island is recognized as one of the world’s biodiversity conservation priority areas, specifically in terms of the number of endemic (or native) species, diversity of habitats, and degrees of threats.  

The MBCFI and the Malampaya Foundation, Inc. (MFI) have been undertaking the protection and preservation of the island, as well as the other key biodiversity areas of north Palawan and the Verde Island Passage.   

Among the various flora and fauna found in the island are the tamaraw or dwarf water buffalo, the Philippine warty pig, the golden-crowned fruit bat, as well as various pine and rattan species. In her presentation, Ms. Diamante shared that Mindoro has more bird species than Madagascar (285 versus 258), known as a globally-recognized megadiversity country. It also has more reptile and amphibian species (70 versus 27) than the United Kingdom, a country with a land area 23 times that of the island.  

“Central Philippines has the most number of marine species per unit area, with particular emphasis on the Verde Island Passage,” said Karen Agabin, executive director of Malampaya Foundation, the social arm of Malampaya Joint Venture partners. The Verde Island Passage is located between the islands of Mindoro and Luzon, and is recognized as the center of global shore-fish biodiversity.   

A February 2013 study by Jonnell C. Sanciangco, et al., however, noted the evidence of exploitation-related biodiversity loss in central Philippines.   

There has been a 90% decline in fish-catch rates since the 1950s to the year 2000, said Ms. Agabin. “Marine protected areas (MPAs) are effective solutions. They can accelerate restoration and [promote the] sustainable use of resources  but only if they are effectively managed,” she added.  

MPAs are established to help protect marine ecosystems that are threatened by human activity, such as overfishing or petroleum drilling. They also provide living laboratories for oceanographers and marine biologists to conduct research, according to National Geographic 

“The prosperity of humans is dependent on biodiversity,” Ms. Agabin said. “Investing in biodiversity means investing in our future.” — Patricia B. Mirasol 

Facebook launches digital journalism course in collaboration with Reuters

UNSPLASH
UNSPLASH

The Facebook Journalism Project (FJP) and the Reuters Institute launched a digital journalism course this May. Developed by Reuters, the online training program has modules on digital news gathering, verification and reporting, publishing on social media, wellness and resilience training while reporting. It aims to build a strong foundation in digital reporting and editing for journalists in eight countries across Asia, including the Philippines.   

Journalists from Thailand, Indonesia, Pakistan, Bangladesh, Sri Lanka, Malaysia, India, South Africa, Nigeria, and Kenya will be able to access the free e-learning program. 

“Facebook is proud to partner with Reuters to launch this new e-learning program and help our region’s journalists build strong foundational knowledge as they navigate the changing digital news landscape. Facebook is committed to supporting the region’s news community and ensuring reporters can continue their important work to keep our communities informed,” said Anjali Kapoor, Facebook Asia Pacific’s director of news partnerships, in a press statement.  

According to Reuters’s latest Digital News Report, 73% of Filipinos on Facebook use the social platform for reading, discussing, and sharing news (the highest percentage among countries surveyed). Meanwhile, 75% use smartphones to access news. 

 The report also found that most people are still not paying for online news. Nic Newman, senior research associate of the Reuters Institute for the Study of Journalism, noted that publishers recognize long-term survival as likely to involve stronger and deeper connection with audiences through formats such as podcasts and e-mail. 

Journalists have the impetus to continue responsible and accurate reporting amid the changes in the media landscape and news consumption habits. The FJP works with publishers around the world to strengthen the connection between journalists and the communities they serve. Its trainings, programs, and partnerships work by: investing in organizations that fund quality journalism; training newsrooms globally; and partnering with publishers and nonprofits to combat misinformation, promote news literacy, and improve journalism.   

Among its initiatives are a $2 million investment in grant funding, coaching, and training to support Asia-Pacific newsrooms during the coronavirus disease 2019 (COVID-19) pandemic; as well as virtual trainings for news publishers and journalists across the region, including the Newsroom Transformation 2020 training program in partnership with the World Association of News Publishers (WAN-IFRA).   Patricia B. Mirasol 

Malaysia’s AirAsia X gets shareholder go-ahead for restructuring plan 

Image via AirAsia Group Bhd.

KUALA LUMPUR  AirAsia X Bhd. shareholders have approved the Malaysian budget airline’s debt restructuring, it said on Tuesday, allowing it to pursue a scheme it viewed as key to survival. 

Shareholders of the long-haul affiliate of AirAsia Group Bhd. approved all resolutions at an extraordinary general meeting, including a rights issue and a share subscription for new investors to raise 500 million ringgit. 

AirAsia X last October proposed restructuring its 64.15 billion ringgit ($15.6 billion) debt into a principal amount of 200 million ringgit and having the rest waived. 

The airline said in a separate statement that the resolutions were passed with at least a 99.8% margin, and marked a major milestone in its restructuring progress. 

“These approvals have been obtained simultaneously with final negotiations being held with creditors,” it said, adding that with advisers New York-based Seabury Capital it had been “in active and productive” talks with lessors and others. 

A Malaysian court in February granted the airline leave to convene separate meetings with its different groups of creditors within six months, to vote on its scheme. 

The meeting is scheduled for late July or August, AirAsia X said. 

In March, the court also granted AirAsia X a three-month order against any proceedings that may be filed against it, which could have slowed down its restructuring. 

Planemaker Airbus last year joined more than a dozen creditors to challenge the debt restructuring plan, telling the court it stands to lose more than $5 billion worth of orders if the proposal goes through. 

Other challengers include lessor BOC Aviation (BOCA), which called for a debt-to-equity swap. 

Airbus said it cannot comment on the airline’s ongoing restructuring plan, while BOCA said it does not comment on individual customers. 

AirAsia X in February proposed a separate restructuring program for its aircraft lessors that aims to address their concerns about forward commercial agreements and the viability of the airline’s business after recapitalisation. ($1 = 4.1240 ringgit)  — Liz Lee/Reuters 

Own premium freebies by pre-ordering the new vivo V21 series

Tech enthusiasts can now have the newly released vivo V21 5G and V21e. Pre-ordering the smartphone from June 1 to 4 comes with an exclusive set of premium freebies, like Bluetooth speaker and earbuds, on top of a generous screen warranty.

The vivo V21 5G, priced at P23,999, has exciting camera features. The ultra-sleek device is also recognized as the thinnest 5G capable selfie phone in the market today. It is bundled with a premium-grade Bluetooth speaker, plus a 6-month screen warranty, collectively valued at P4,499. See the full features at https://www.vivoglobal.ph/phone/vivo-V21-5g/.

For a much more affordable choice, the slim and fun vivo V21e sells at only P17,999. It is bundled with Bluetooth-enabled TWS Earbuds, and 6-month screen warranty, for a total freebie value of P3,499. Learn more about this new smartphone at https://www.vivoglobal.ph/phone/vivo-V21e/.

The vivo V21 series transforms the photography experience with its expert-grade yet easy-to-use camera features. Regarded as “the new portrait master,” the smartphone lets its users snap portraits with a professional-looking quality.

The V21 5G comes in appealing colors including Sunset Dazzle and Dusk Blue (AG Matte Glass). The smartphone captivates further with its ultra-slim width of 7.29mm.

Even with its lightweight look, the V21 5G boasts of its heavy-weight capacities in taking pictures, especially portraits. The smartphone’s Dual Selfie Spotlight, Dual-View Video, and Ultra Stable Selfie Video features empower users to take superior photos. Granting its excellent image quality results is vivo’s reliable 44MP OIS Self Portrait, and 64MP OIS Night Camera.

Additionally, the smartphone’s usage of Dimensity 800U 5G Processor, 8GB + 3GB Extended RAM, and 90Hz High Refresh Rate creates an enjoyable, smooth, and all-day performance for the users.

On the other hand, the V21e is available in striking colors such as Roman Black and Diamond Flare (Ultra-thin AG glass). Adding to the smartphone’s exquisite design is its ultra-slim width of 7.38mm.

The V21e is also ready to capture any fun photography adventures. Equipped with a 44MP Eye Autofocus Self Portrait, and a 64MP Night Camera, the smartphone will amuse its users with its features such as Instagram-quality, Super Night Selfie, Dual-View Videos, and Motion Autofocus.

Furthermore, the V21e’s use of Qualcomm® Snapdragon™ 720G, 8GB + 3GB extended RAM, and 33W FlashCharge technology (Type-C) will truly give satisfaction to the users.

Enjoy the impressive features of vivo V21 Series ahead of everyone by pre-ordering from June 1 to 4. Customers who will pre-order just need to pay a P500 down payment, which will be deducted from the phone’s retail price. When claiming the device, simply present valid, government-issued identification, receipt of the down payment, the claiming voucher (plus a Letter of Authorization if a representative will claim it).

Beginning June 5, vivo’s V21 Series will be available in select vivo stores. The V21e will also have a P1,000 off sale on its first week, from June 1 to 15. Users can get it at P16,999 from its original price of P17,999.

For more details, visit https://www.vivoglobal.ph/phone/vivo-V21e/ or visit vivo Philippines on Facebook, Twitter, and Instagram. The new phones are also available for purchase at vivo’s official Lazada and Shopee stores.

Japan to donate additional $800 million, vaccines to WHO’s COVAX body — media

BLOOMBERG

TOKYO  Japanese Prime Minister Yoshihide Suga is planning to pledge an additional $800 million to the World Health Organization’s COVAX program, which provides coronavirus disease 2019 (COVID-19) vaccines to countries in need, the Mainichi newspaper reported on Wednesday. 

Japan has already pledged $200 million to COVAX, and the country is expected to announce donations of vaccine doses to the program, the newspaper said without citing a source. 

Mr. Suga will serve as host for an online COVAX summit on Wednesday, which will also be attended by United States Vice President Kamala Harris, philanthropist Bill Gates, and representatives from Group of Seven nations. 

The summit is intended to fill a $1.7 billion funding gap, and it is hoped that countries and organizations will boost their pledges of money and vaccine doses, a Japanese government official told reporters on Tuesday. 

Japanese lawmakers have urged giving supplies of AstraZeneca Plc’s vaccine to Taiwan, which is dealing with a spike in domestic infections and has vaccinated less than 2% of its 23.5 million population. Japan has no immediate plans to use the AstraZeneca doses it has on hand and has secured enough supplies of other types of vaccine for its entire population. — Reuters 

Israel sees probable link between Pfizer vaccine and myocarditis cases

JERUSALEM  Israel’s Health Ministry said on Tuesday it found the small number of heart inflammation cases observed mainly in young men who received Pfizer’s coronavirus disease 2019 (COVID-19) vaccine in Israel were likely linked to their vaccination. 

Pfizer has said it has not observed a higher rate of the condition, known as myocarditis, than would normally be expected in the general population. 

In Israel, 275 cases of myocarditis were reported between December 2020 and May 2021 among more than 5 million vaccinated people, the ministry said in disclosing the findings of a study it commissioned to examine the matter. 

Most patients who experienced heart inflammation spent no more than four days in hospital and 95% of the cases were classified as mild, according to the study, which the ministry said was conducted by three teams of experts. 

The study found “there is a probable link between receiving the second dose (of Pfizer) vaccine and the appearance of myocarditis among men aged 16 to 30,” it said in a statement. 

According to the findings, such a link was observed more among men aged 16 to 19 than in other age groups. 

Pfizer said in a statement that it is aware of the Israeli observations of myocarditis, noting that no causal link to its vaccine has been established. 

Adverse events are thoroughly reviewed and Pfizer meets regularly with the Vaccine Safety Department of the Israeli Ministry of Health to review data, it said. 

A US Centers for Disease Control and Prevention (CDC) advisory group last month recommended further study of the possibility of a link between myocarditis and mRNA vaccines, which include those from Pfizer and Moderna Inc. 

CDC monitoring systems had not found more cases than would be expected in the population, but the advisory group said in a statement that members felt healthcare providers should be made aware of reports of a “potential adverse event.” 

The Israeli ministry released the statement, which contained no recommendations, ahead of a widely expected decision on whether to begin vaccinating youngsters aged 12 to 15 in Israel. 

It said a team examining that issue would make its recommendation to the ministry’s director-general, but gave no date. 

Israeli media reports said a decision on including the 1215 age group in the country’s vaccination program could come as early as Sunday. 

Israel has been a world leader in its vaccination rollout. 

With COVID-19 infections down to just a handful a day and total active cases at just 340 across the country, the economy has fully opened, though restrictions remain on incoming tourism. 

Some 55% of Israel’s population has already been vaccinated. As of Tuesday, restrictions on social distancing and the need for special green vaccination passes to enter certain restaurants and venues were scrapped. — Reuters 

Jakarta startup provides cleaning products without the plastics

Image via Siklus

JAKARTA  Just a few hours after using a mobile app to order some dishwashing liquid, Jakarta resident Juweriah opens the door to a motorbike courier who provides a direct refill in her kitchen. 

Juweriah, who like many Indonesians goes by one name, is taking advantage of a rise in environmentally friendly businesses in a country that is the second-largest ocean plastic polluter in the world. 

The 38-year-old homemaker orders products through Siklus, a startup that provides cleaning and sanitary products minus plastic packaging to homes and businesses in the Indonesian capital. 

“We can refill (the bottles) and reduce the amount of detergent plastic waste,” Juweriah said. “Neighbours here have followed suit.” 

Siklus, launched in 2019, aims to reduce the number of products packaged in sachets, which are particularly popular among lower-income communities. Siklus means “cycle” in Bahasa Indonesia. 

Selling for around 800 rupiah (5 cents), single-use sachets give some of the poorest people in Asia access to everyday household essentials, but they also generate a significant amount of waste, clogging waterways and oceans. 

Indonesia generates approximately 7.8 million tons of plastic waste annually, with 4.9 million tons of waste mismanaged, according to a World Bank report in May. Limited waste management collection infrastructure is one of the main problems, according to the report. 

Siklus Chief Executive Jane von Rabenau, 28, said the response to the product had been positive, with the company increasing its customer base by around 15% each week. 

“People have always told me ‘you’re never going to change the behavior, Indonesians don’t care’ and I was like, I really don’t think so,” she said. “I think Indonesians across all classes they see the plastic problem, and they care about their country, they care about making it better.” 

Jakarta food stall owner Husaifah was attracted to Siklus by low prices as well as its environmental credentials. Dispensing with packaging allows the company to significantly reduce end costs. 

“It’s practical,” Husaifa said. “The cost is low, and we don’t have to go out, it comes to us.” — Reuters 

Amazon backs marijuana legalization, drops weed testing for some jobs

Amazon.com Inc. said on Tuesday it supports a proposed US legislation to legalize cannabis at the federal level, and would drop weed-testing requirements for some recruitments. 

 The e-commerce company’s public policy team will be actively supporting The Marijuana Opportunity Reinvestment and Expungement Act of 2021 (MORE Act), which seeks to legalize marijuana at the federal level, its consumer boss Dave Clark said in a blog post. 

Amazon will also no longer screen its job applicants for marijuana use for any positions not regulated by the Department of Transportation, Mr. Clark added. 

While many US states have legalized marijuana use, employers have so far largely refused to work with the industry as cannabis is still a classified substance at the federal level. 

“In the past, like many employers, we’ve disqualified people from working at Amazon if they tested positive for marijuana use,” Mr. Clark said. “However, given where state laws are moving across the U.S., we’ve changed course.” 

Amazon was hit with a proposed class action suit, which claimed that the company was violating a New York City law by testing applicants for jobs at local facilities for marijuana, according to a Westlaw report. 

The company does not allow marijuana sales on its platform. 

Amazon also said it is tweaking its worker productivity tracking tool, “Time off Task.” 

“Starting today, we’re now averaging Time off Task over a longer period to ensure that there’s more signal and less noise — reinforcing the original intent of the program,” Mr. Clark said. — Reuters 

US Supreme Court rebuffs J&J appeal over $2 billion baby powder judgment

Image by Mike Mozart/Flickr/ CC BY 2.0

WASHINGTON  The US Supreme Court on Tuesday declined to hear Johnson & Johnson’s (J&J) bid to overturn a $2.12 billion damages award to women who blamed their ovarian cancer on asbestos in the company’s baby powder and other talc products. 

 The justices turned away a J&J appeal and left in place a Missouri state court ruling in litigation brought by 22 women whose claims were heard together in one trial. 

 The Missouri Court of Appeals, an intermediate state appellate court, last year ruled against J&J’s bid to throw out the compensatory and punitive damages awarded to the plaintiffs but reduced the total to $2.12 billion from the $4.69 billion originally decided by a jury. 

J&J, which will make a payment of $2.5 billion this month including accrued interest, said in a statement that there are unresolved legal issues that will continue to be litigated. It previously has said it faces more than 19,000 similar claims. 

“The matters that were before the court are related to legal procedure, and not safety. Decades of independent scientific evaluations confirm Johnson’s Baby Powder is safe, does not contain asbestos, and does not cause cancer,” the company said. 

J&J shares were down about 1.2% at $167.23. 

J&J has argued that a decision by a Missouri circuit court judge to consolidate disparate baby powder-related claims from the plaintiffs  including 17 women from outside the state  for a trial before a single jury violated the New Brunswick, New Jersey-based company’s due process rights under the U.S. Constitution. J&J also has argued that the size of the jury’s damages award violated its due process rights. 

The Missouri Supreme Court, the state’s highest court, in November declined to hear J&J’s appeal of the Missouri Court of Appeals ruling, prompting the company to appeal to the US Supreme Court. 

“This was a victory not just for the amazing women and their families who we were privileged to represent, but a victory for justice,” said Mark Lanier, a lawyer for the plaintiffs. 

DISPUTE OVER JURISDICTION 

The plaintiffs, nine of whom have died and are now represented by their estates, have argued that Missouri courts have jurisdiction over out-of-state claims like those brought in this litigation. One of the products that the out-of-state plaintiffs said they had used was manufactured in Missouri. 

Lawyers for the plaintiffs also have argued that the large punitive damages awarded by the jury in this case were justified by J&J’s conduct. Lawyers for the plaintiffs said in court papers it is common practice for courts to consolidate cases at trial when the facts in each claim are essentially the same. 

The Missouri Court of Appeals concluded that it was reasonable to infer from the evidence that J&J “disregarded the safety of consumers” in its drive for profit despite knowing its talc products caused ovarian cancer. It also found “significant reprehensibility” in J&J’s conduct. 

In addition to reducing the damages, the Missouri Court of Appeals dismissed two of the 17 out-of-state plaintiffs. 

In court papers, J&J said the case followed a “winning formula” devised by plaintiffs’ lawyers of bringing claims in jurisdictions where they can get dozens of out-of-state plaintiffs to testify in a single trial, prejudicing the jury and resulting in “outsized” damages awards. 

In the Missouri trial, the company said, the jury awarded each plaintiff an identical punitive damages award of $25 million, regardless of the facts specific to each plaintiff or whether they were alive or dead. The company also said the jury awarded punitive damages much larger than the “already staggering” compensatory damages, which J&J has called a further violation of its due process rights. 

Justice Samuel Alito did not participate in the Supreme Court’s decision not to hear the appeal, likely because he owns J&J stock. Justice Brett Kavanaugh, whose father  now retired  was a longtime lobbyist for the toiletries industry, also did not take part. The justices do not explain why they step aside in certain cases. 

 A 2018 Reuters investigation found that J&J knew for decades that asbestos, a carcinogen, was present in its talc products. Internal company records, trial testimony, and other evidence showed that from at least 1971 to the early 2000s, J&J’s raw talc and finished powders sometimes tested positive for small amounts of asbestos. 

The company said in May 2020 it would stop selling its baby powder talc in the United States and Canada, citing changes in consumer habits and what it called “misinformation” about the product’s safety amid numerous legal challenges.  Lawrence Hurley/Reuters 

WHO approves Sinovac COVID shot in second Chinese milestone

REUTERS

GENEVA – The World Health Organization (WHO) said on Tuesday it has approved a COVID-19 vaccine made by Sinovac Biotech for emergency use listing, paving the way for a second Chinese shot to be used in poor countries.

A WHO emergency listing is a signal to national regulators of a product’s safety and efficacy and will allow the Sinovac shot to be included in COVAX, the global programme providing vaccines mainly for poor countries, which faces major supply problems due to curbs on Indian exports.

The WHO’s independent panel of experts said in a statement it recommended Sinovac’s vaccine for adults over 18. There was no upper age limit as data suggested it is likely to have a protective effect in older people.

The WHO’s technical advisory group, which began meeting on May 5, made the decision after reviewing the latest clinical data on the Sinovac vaccine’s safety and efficacy as well as the company’s manufacturing practices.

WHO Director-General Tedros Adhanom Ghebreyesus welcomed the move, calling the vaccine safe and effective and noting its easy storage requirements make it suitable for low-income countries.

“It’s now crucial to get these lifesaving tools to the people that need them quickly,” he told a briefing.

Branded CoronaVac in some regions, it is the eighth vaccine to win such a WHO listing to combat COVID-19 and the second developed by a Chinese company, after the May 7 approval of a shot developed by state-backed Sinopharm.

While a third Chinese vaccine, produced by CanSino Biologics , has submitted clinical trial data, no WHO review has been scheduled.
Sinovac said that it had supplied more than 600 million doses of its vaccine at home and abroad as of end-May and over 430 million doses have been administered.

BIG BOOST

The endorsement is a big boost for Sinovac’s vaccine after data in clinical trials showed a wide range of efficacy rates.

The WHO said results showed it prevented symptomatic disease in 51% of those vaccinated and prevented severe COVID-19 and hospitalisation in 100% of the studied population.

The WHO’s separate Strategic Advisory Group of Experts (SAGE) had said previously that vaccine efficacy in multi-country Phase III clinical trials ranged from 51% to 84%.

Indonesia said on May 12 that its study of 120,000 healthcare workers who had received the vaccine found it was 94% effective at preventing symptomatic disease.

In a preliminary evaluation, the SAGE panel found that the shot was effective in preventing COVID-19 in adults under 60, but that some quality data on the risk of serious adverse effects was lacking.

It cited evidence gaps in safety in pregnancy, and on safety and clinical protection in older adults, those with underlying disease, and evaluation of rare adverse events.

SAGE experts, who issue policy recommendations to states and dosage guidelines, reviewed Sinovac clinical data last month.

Sinovac chairman and chief executive Weidong Yin said in a statement that clinical trials had provided a “solid scientific foundation” for the drugmaker’s shot to be approved by more than 40 countries and by the WHO.

China has already deployed hundreds of millions of doses of both Sinopharm and Sinovac vaccines at home and exported them to many countries, particularly in Africa, Asia and Latin America. — Reuters